Navigation Links
SyntheMed Announces FDA Clearance of SinusShield(TM)
Date:11/19/2008

awaiting FDA approval to market in the United States.

Statements in this press release that are not statements of historical fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve market potential, distribution strategies, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include but are not limited to (i) potential adverse developments regarding the company's efforts to obtain and maintain required regulatory approvals; (ii) potential inability to secure funding as and when needed to support the company's future activities and (iii) unanticipated delays associated with manufacturing and marketing activities. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 for a description of these, as well as other, risks and uncertainties.


'/>"/>
SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
2. SyntheMed to Present at the Acumen BioFin Conference
3. SyntheMed Files Universal Shelf Registration
4. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
5. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
6. SyntheMed Completes $4.0 Million Equity Placement
7. SyntheMed Announces New Management Appointments
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... , Product release is a r...ch subjects, research facilities and research safe...ation. , Cedar Knolls, NJ...s announced today that it has unveiled Pristima&tr...n for research facilities that track the use and c...
(Date:11/6/2009)... , TORONTO, Nov. 6 /PRNewswire-FirstCall/ - M...today that it has re-filed the Form 52-109F1 Certi...Chief Executive Officer and James Long, the Chief ...ated January 12, 2009 in connection with the annua...September 30, 2008. ,, The Company initially fi...
(Date:11/6/2009)... , SAN MATEO, Calif., Nov. 6 /PRNewswire-Firs..., Completed transfer of Qutenza(TM) E.U. Market... Made significant progress in commercial readiness...P Sales; Senior Director, Marketing; and Director,...win to board as director and Audit Committee chair...
(Date:11/5/2009)... , , TRANSPORTATION -- Gone hybrid . . . , F...tomobiles are now posted at the www.fueleconomy.g...developed and maintains for the U.S. Department of...cy. Nine of the top 10 vehicles on the best fuel e...a Prius (51 MPG city; 48 highway). "This list prov...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...ISCO, Dec. 9 Medivation, Inc.,(Nasdaq: MDVN ) p... that,Dimebon, its lead product candidate in devel...ses, potentially operates via a novel mitochondria...ebon was shown to impact two,key aspects of brain ...t,preserved mitochondrial function after brain cel...
... Conn., Dec. 9 Soliris(R) (eculizumab),a terminal...euticals, Inc.,(Nasdaq: ALXN ), was observed by ...with undiagnosed blood clots and inflammation in p...hat Soliris was observed to reduce indicators of,p...h paroxysmal nocturnal,hemoglobinuria (PNH), accor...
... Oberon FMR, Inc. was selected as...e recent BioWest 2008 Venture Showcase Competition...vert wastewater from food and beverage companies i... given top honors out of 22 total entries by a pan...m the sponsoring Colorado law firm of Dorsey &...
Other Biology Technology:Medivation Presents New Data on Dimebon's Novel Mechanism of Action 2Medivation Presents New Data on Dimebon's Novel Mechanism of Action 3Medivation Presents New Data on Dimebon's Novel Mechanism of Action 4Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 2Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 3Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 4Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 5Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 6Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 7Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 8Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, M...LEID) will be installing its locker system and pat...ACS) at the U.S. Department of Health and Human Se...in Bethesda, MD. The locker system will support t...or protecting our nation,s medical research agency...
(Date:11/5/2009)...ent State University has been awarded a training g...cience Foundation under its Integrative Graduation...This is the first IGERT grant to be awarded to Ken...ican Recovery and Reinvestment Act of 2009, runs t...that focuses on environment aquatic resource sensi...
(Date:11/4/2009)...t. Louis, MO, November 4, 2009 Childhood obesity ...ons. With more than one fourth of advertising on d...and beverages and continuing questions about the r...vember/December issue of the Journal of Nutrition...sing aimed at children might be a large contributo...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2Imagewrks Marketing Named Among Top 50 Fastest Growing Private Companies in Minnesota 60402 1Imagewrks Marketing Named Among Top 50 Fastest Growing Private Companies in Minnesota 60402 2Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 1Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 2Survey of State Health Departments Underscores Gaps in Foodborne Illness Response 60398 3
...hange causes temperatures to increase in Hawaii,s ...kely also creep up the mountains, invading most of...a group of endangered and remarkable birds. , A ...w discusses the likelihood of a forthcoming "disea...range of avian malaria and pox, honeycreeper distr...
... Stem cells that respond after a severe injury in...ding cells that lead to lung cancer, according to ...There are chemically resistant, local-tissue stem ...injury," said Barry R. Stripp, Ph.D., professor of...cal Center. "Cigarette smoke contains a host of to...
...ier is wounded during combat, surgeons must focus ...one and tissues. Technologies that could improve t...eloped in research laboratories across the country... military trauma centers. , Organizers of the rec... Bioengineering for Soldier Survivability want to ...
Other Biology News:Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3Activated stem cells in damaged lungs could be first step toward cancer 2New center at Georgia Tech aims to improve recovery of soldiers with severe injuries 2New center at Georgia Tech aims to improve recovery of soldiers with severe injuries 3
Rabbit Anti-Shigella Polyclonal Antibody, Unconjugated from GeneTex
...UL-3 is a member of the family of human cullin gen...o the S. cerevisiae cdc53 gene. Cullin-3 is propos...t forms a tight complex with cyclin E and targets ...ion by protesomes. Cyclin E is an activator of cdk...
...lue LED produces output at 470 nm; includes interf...r installed into rack or desktop boxes The LS-45...uces either pulsed or continuous output at 470 nm ...s. The source is designed for use with Ocean Optic...
Freund's Complete Adjuvant, Modified, Mycobacterium butyricum from Calbiochem
Biology Products: